Skip to main content
. 2021 Nov 8;9:738081. doi: 10.3389/fbioe.2021.738081

FIGURE 3.

FIGURE 3

Alginate microencapsulated vHepLPC spheroids significantly improved the survival rate of mice with liver injury. (A) Alginate microcapsule coating protocol diagram. (B) Bright-field image of coated spheroids. (C) Cell viability test after microencapsulation. (D) Survival curve for acute liver injury mice with microencapsulated HepLPC spheroids (n = 10), vHepLPC spheroids (n = 11), or empty (n = 6) transplantation. (E) The microcapsule particles were enriched around the liver after transplantation. (F) Microcapsules recovered from the mouse abdominal cavity. (G) Serum levels of ALT and AST in CCL4-treated mice before and after transplantation (days one through seven) of microencapsulated spheroids. (H) Serum levels of human albumin secretion in CCL4-treated mice. (I) H&E staining 7 days after transplantation of alginate microencapsulated spheroids. The liver tissue after transplantation was significantly closer to normal tissue morphology. Data are presented as means ± SEM. **p < 0.01. Scale bars, 100 µm.